Skip to main content

Databases for Studying the Epidemiology of Implanted Medical Devices

  • Chapter
The Bionic Human

Abstract

The worldwide market for implanted medical devices continues to accelerate from $41.7 billion in 1993 to $56.7 billion in 1995 (1). Unlike epidemiological research for pharmaceuticals, which builds knowledge on clinical trials that are typically completed in several months, clinical trials for implanted medical devices require longer follow-up to determine safety and efficacy. Follow-up for the purpose of regulatory approval is usually complete in 1 or 2 years, but practitioners and patients are interested in the safety and efficacy of implants for the entire life span of patients. This was highlighted in the development of a National Institutes of Health (NIH) Technology Assessment Panel Consensus Statement on Implant Registries (2). The panel noted that 20 to 25 million US patients have had a medical device implanted. Device epidemiology provides a scientific method to contribute to this area of inquiry.

The views expressed here are those of the authors and are not the official position of the US Food and Drug Administration.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Allen A. Medical Device Industry Fact Book (3rd ed.) Santa Monica, CA: Canon ommunications, Inc., 1996.

    Google Scholar 

  2. Marwick C. Implant recommendations [news]. JAMA 2000;283:869.

    Article  CAS  Google Scholar 

  3. Ahlbom A, Norell S. Introduction to modern epidemiology. Chestnut Hill, MA: Epidemiology Resources, 1984.

    Google Scholar 

  4. Moss AJ, Hamberger S, Moore RM, Jeng LL, Howie LJ. Use of selected medical device implants in the United States, 1988: Advance data from vital and health statistics. No. 191. 2000. Hyattsville, MD: National Center for Health Statistics.

    Google Scholar 

  5. Bright RA, Jeng LL, Moore RM. National survey of self-reported breast implants: 1988 estimates. J Long Term Eff Med Implants 1993;3:81–89.

    CAS  Google Scholar 

  6. Bright RA, Moore RM, Jr., Jeng LL, Sharkness CM, Hamburger SE, Hamilton PM. The prevalence of tympanostomy tubes in children in the United States, 1988. Am J Public Health 1993;83:1026–1028.

    Article  CAS  Google Scholar 

  7. Garver D, Kaczmarek RG, Silverman BG, Gross TP, Hamilton PM. The epidemiology of prosthetic heart valves in the United States. Tex Heart Inst J 1995;22:86–91.

    CAS  Google Scholar 

  8. Moore RM, Jr., Hamburger S, Jeng LL, Hamilton PM. Orthopedic implant devices: prevalence and sociodemographic findings from the 1988 National Health Interview Survey. J Appl Biomater 1991;2:127–131.

    Article  Google Scholar 

  9. Moore RM, Jr., Bright RA, Jeng LL, Sharkness CM, Hamburger SE, Hamilton PM. The prevalence of internal orthopedic fixation devices in children in the United States, 1988. Am J Public Health 1993;83:1028–1030.

    Google Scholar 

  10. Sharkness CM, Hamburger S, Kaczmarek RG, Hamilton PM, Bright RA, Moore RM, Jr. Racial differences in the prevalence of intraocular lens implants in the United States. Am J Ophthalmol 1992;114:667–674.

    CAS  Google Scholar 

  11. Sharkness CM, Hamburger S, Moore RM, Jr., Kaczmarek RG. Prevalence of artificial hips in the United States. J Long Term Eff Med Implants 1992;2:1–8.

    CAS  Google Scholar 

  12. Sharkness CM, Hamburger S, Moore RM, Jr., Kaczmarek RG. Prevalence of artificial hip implants and use of health services by recipients. Public Health Rep 1993;108:70–75.

    CAS  Google Scholar 

  13. Silverman BG, Gross TP, Kaczmarek RG, Hamilton P, Hamburger S. The epidemiology of pacemaker implantation in the United States. Public Health Rep 1995;110:42–46.

    CAS  Google Scholar 

  14. Silverman BG, Gross TP, Kaczmarek RG, Hamilton P, Hamburger S. Epidemiology of artificial knee implantation in the USA. The Knee 1995;2:95–102.

    Article  Google Scholar 

  15. National Center for Health Statistics. Surveys and Data Collection Systems: National Health Interview Survey on Disability (NHIS-D). http://www.cdc.gov/nchs/about/major/nhis_dis/nhis_dis.htm. Accessed 2005.

  16. National Center for Health Statistics. 1994 National Health Interview Survey on Disability, Phase I and Phase II. Available at: http://www.cdc.gov/nchs/about/major/nhis_dis/nhisddes.htm. Accessed 2000.

  17. National Center for Health Statistics. Survey and data collection systems: National Health Interview Survey of Disability (NHIS-D). Available at: http://www.cdc.gov/nchs/about/major/nhis_dis/nhis_dis.htm. Accessed 2005.

  18. National Center for Health Statistics. The mortality followback survey program. Available at: http://www.cdc.gov/nchs/about/major/nmfs/desc.htm. Accessed 2000.

  19. National Center for Health Statistics. National Mortality Followback Survey. http://www.cdc.gov/nchs/about/major/nmfs/nmfs.htm. Accessed 2003.

  20. National Center for Health Statistics. NHAMCS description. Available at: http://www.cdc.gov/nchs/about/major/ahcd/nhamcsds.htm. Accessed 2000.

  21. National Center for Health Statistics. NAMCS description. Available at: http://www.cdc.gov/nchs/about/major/ahcd/namcsdes.htm. Accessed 2000.

  22. National Center for Health Statistics. Survey instrument: national hospital ambulatory medical care and national ambulatory medical care surveys. Available at: http://www.cdc.gov/nchs/about/major/ahcd/surinst.htm. Accessed 2000.

  23. Hospital Supply Index: Product analyses. Volume 1A. Plymouth Meeting, PA: IMS America, 1995.

    Google Scholar 

  24. Riordan P, Bickler G, Lyons C. Lessons of a hip failure. Registers of joint replacement operations should be set up [letter; comment]. BMJ 1998;316(7149):1985.

    CAS  Google Scholar 

  25. Miles J. National registry is also needed for neurological implants [letter; comment]. BMJ 1998;317(7173):1658–1659.

    CAS  Google Scholar 

  26. Product Performance Report: Bradycardia Products. Minneapolis, MN; Medtronic, Inc., 1998.

    Google Scholar 

  27. Rettig RA. The industrialization of clinical research. Health Aff (Millwood) 2000;19:129–146.

    Article  CAS  Google Scholar 

  28. Eichenwald K, Kolata G. When physicians double as businessmen. The New York Times 1999; November 30, p. A1.

    Google Scholar 

  29. Ramsey SD, Pauly MV. Structural incentives and adoption of medical technologies in HMO and fee-for-service health insurance plans. Inquiry 1997;34:228–236.

    CAS  Google Scholar 

  30. Chernew M, Fendrick AM, Hirth RA. Managed care and medical technology: implications for cost growth. Health Aff (Millwood ) 1997;16:196–206.

    Article  CAS  Google Scholar 

  31. Steiner CA, Powe NR, Anderson GF, Das A. Technology coverage decisions by health care plans and considerations by medical directors. Med Care 1997;35:472–489.

    Article  CAS  Google Scholar 

  32. Saksema S, Madan N, Lewis C. Implantable cardioverter-defibrillators are preferable to drugs as primary therapy in sustained ventricular tachyarrhythmias. Prog Cardiovasc Dis 1996;38:445–454.

    Article  Google Scholar 

  33. Hawker GA, Coyte PC, Wright JG, Paul JE, Bombardier C. Accuracy of administrative data for assessing outcomes after knee replacement surgery. J Clin Epidemiol 1997;50:265–273.

    Article  CAS  Google Scholar 

  34. Steinberg EP, Whittle J, Anderson GF. Impact of claims data research on clinical practice. Int J Technol Assess Health Care 1990;6:282–287.

    CAS  Google Scholar 

  35. McDonald CJ, Overhage JM, Dexter P, Takesue BY, Dwyer DM. A framework for capturing clinical data sets from computerized sources. Ann Intern Med 1997;127(8 Pt 2):675–682.

    CAS  Google Scholar 

  36. Waid MO. Brief summaries of Medicare and Medicaid: Title XVIII and Title XIX of the Social Security Act. Baltimore, Md; Health Care Financing Administration, Department of Health and Human Services, 1998.

    Google Scholar 

  37. Helbing C, Schieber G. Use of Medicare data in international comparisons. Health Policy 1990;15:45–66.

    Article  CAS  Google Scholar 

  38. International Classification of Diseases, 9th Revision. Clinical Modification (ICD-9-CM). U.S. Department of Health and Human Services, ed. Washington, DC: Public Health Service, Health Care Financing Administration, 1991.

    Google Scholar 

  39. Medicare’s National Level II Codes, 1998: HCPCS. Dover, DE: American Medical Association, 1997.

    Google Scholar 

  40. The USRDS and its products. Am J Kidney Dis 1999;34(2 Suppl 1):S20–S39.

    Google Scholar 

  41. Healthcare Cost and Utilization Project (HCUP-3), Nationwide Inpatient Sample. Agency for Health Care Policy and Research, ed. Release 3. Rockville, MD, 1994.

    Google Scholar 

  42. Cochran WG. Sampling techniques (3rd ed.). New York: Wiley, 1977.

    Google Scholar 

  43. Korn EL, Graubard BI. Analysis of health surveys. New York: Wiley, 1999.

    Google Scholar 

  44. Design and estimation for the National Health Interview Survey, 1995–2004. Hyattsville, MD: National Center for Health Statistics, Vital and Health Statistics, Series 2;1997.

    Google Scholar 

  45. Brogan DJ. Software for sample survey data: misuse of standard packages. In: Armitage P, Colton T, eds. Encyclopedia of Biostatistics. New York: Wiley, 1998, 4167–4174.

    Google Scholar 

  46. Shah BV, Barnwell BG, Bieler GS. SUDAAN User’s Manual, Release 7.0. Research Triangle Park, NC: Research Triangle Institute, 1996.

    Google Scholar 

  47. Stata Statistical Software. College Station, TX: Stata Corporation, 1997.

    Google Scholar 

  48. Strom BL. Pharmacoepidemiology (3rd ed.). Sussex, UK: Wiley, 2000.

    Google Scholar 

  49. Woosley RL. Centers for education and research in therapeutics [see comments]. Clin Pharmacol Ther 1994;55:249–255. Overview: Centers for Education and Research on Therapeutics. Available at: http://www.certs.hhs.gov. Accessed 2005.

    Article  CAS  Google Scholar 

  50. Brewer T, Colditz GA. Postmarketing surveillance and adverse drug reactions: current perspectives and future needs. JAMA 1999;281:824–829.

    Article  CAS  Google Scholar 

  51. Blais R. Using administrative data bases for technology assessment in health care. Results of an international survey. Int J Technol Assess Health Care 1991;7:203–208.

    CAS  Google Scholar 

  52. Glikson M, Hyberger LK, Hitzke MK, Kincaid DK, Hayes DL. Clinical surveillance of a tined, bipolar, steroid-eluting, silicone-insulated ventricular pacing lead. Pacing Clin Electrophysiol 1999;22:765–768.

    Article  CAS  Google Scholar 

  53. Chamberlain-Webber R, Barnes E, Papouchado M, Crick JP. Long-term survival of VDD pacing. Pacing Clin Electrophysiol 1998;21(11 Pt 2):2246–2248.

    Article  CAS  Google Scholar 

  54. Greenland S, Finkle WD. A case-control study of prosthetic implants and selected chronic diseases [published erratum appears in 1997;7:367]. Ann Epidemiol 1996;6:530–540.

    Article  CAS  Google Scholar 

  55. Greenland S, Finkle WD. A case-control study of prosthetic implants and selected chronic diseases in Medicare claims data. Ann Epidemiol 1998;8:319–326.

    Article  CAS  Google Scholar 

  56. Wheatley DJ, Crawford FA, Kay PH, et al. A ten-year study of the Ionescu-Shiley low-profile bioprosthetic heart valve. Eur J Cardiothorac Surg 1994;8:541–548.

    Article  CAS  Google Scholar 

  57. Rabago G, Corbi P, Tedy G, et al. Five-year experience with the Medtronic Hall prosthesis in isolated aortic valve replacement. J Card Surg 1993;8:85–88.

    Article  CAS  Google Scholar 

  58. Lafata JE, Koch GG, Ward RE. Synthesizing evidence from multiple studies. The role of meta-analysis in pharmacoeconomics. Med Care 1996;34(12 Suppl):DS136–DS145.

    CAS  Google Scholar 

  59. Temple R. Meta-analysis and epidemiologic studies in drug development and postmarketing surveillance. JAMA 1999;281:841–844.

    Article  CAS  Google Scholar 

  60. Berlin JA, Colditz GA. The role of meta-analysis in the regulatory process for foods, drugs, and devices. JAMA 1999;281:830–834.

    Article  CAS  Google Scholar 

  61. Da Costa A, Kirkorian G, Cucherat M, et al. Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis. Circulation 1998;97:1796–1801.

    Google Scholar 

  62. Foote SB. Managing the medical arms race: public policy and medical device innovation. Berkley: University of California Press, 1992.

    Google Scholar 

  63. Institute of Medicine. Assessing medical technologies. 2. Washington, DC, National Academy Press, 1985.

    Google Scholar 

  64. Brook RH, Lohr KN. Efficacy, effectiveness, variations, and quality. Boundary-crossing research. Med Care 1985;23:710–722.

    Article  CAS  Google Scholar 

  65. Ramsey SD, Luce BR. Technology assessment of medical devices. Am J Manag Care 1998;25:SP113–114.

    Google Scholar 

  66. Braslow NM, Shatin D, McCarthy DB, Newcomer LN. Role of technology assessment in health benefits coverage for medical devices. Am J Manag Care 1998;4 Spec No:SP139–SP150.

    Google Scholar 

  67. Goodman CS. Healthcare technology assessment: methods, framework, and role in policy making. Am J Manag Care 1998;4 Spec No:SP200–SP214.

    Google Scholar 

  68. Ramsey SD, Luce BR, Deyo R, Franklin G. The limited state of technology assessment for medical devices: facing the issues. Am J Manag Care 1998;4 Spec No:SP188–SP199.

    Google Scholar 

  69. Priester R. Using technology appropriately. Challenges for Minnesota’s Health Technology Advisory Committee. Minn Med 1994;77:25–29.

    CAS  Google Scholar 

  70. Mendelson DN, Abramson RG, Rubin RJ. State involvement in medical technology assessment. Health Aff (Millwood) 1995;14:83–98.

    Article  CAS  Google Scholar 

  71. ECRI. Tour Our World: ECRI; a nonprofit agency. Available at: http://www.healthcare.ecri.org/. Accessed 2000.

  72. Medical Data International. Medical Data International: MDI Online. Available at: http://www.medicaldata.com. Accessed 2000.

  73. Rettig RA. Health care in transition: technology assessment in the private sector. Santa Monica, CA: RAND, 1997.

    Google Scholar 

  74. Perry S, Thamer M. Medical innovation and the critical role of health technology assessment. JAMA 1999;282:1869–1872.

    Article  CAS  Google Scholar 

  75. Mark DH, Glass RM. Impact of new technologies in medicine: a global theme issue [editorial]. JAMA 1999;282:1875.

    Article  CAS  Google Scholar 

  76. Eisenberg JM. Ten lessons for evidence-based technology assessment. JAMA 1999;282:1865–1869.

    Article  CAS  Google Scholar 

  77. National Institute for Clinical Excellence. National Institute for Clinical Excellence: NHS. Available at: http://www.nice.org.uk. Accessed 2000.

  78. Bruning CO, III, Breslin DS, Morgentaler A, Staskin DR. Experience with the penile prosthesis and artificial urinary sphincter. J Long Term Eff Med Implants 1995;5:27–45.

    Google Scholar 

  79. Melton LJ, III. The threat to medical-records research. N Engl J Med 1997;337:1466–1470.

    Article  Google Scholar 

  80. Pharmacoepidemiology. Available at: http://www.pharmacoepi.org/resources/cfr_parts.cfm. Accessed 2005.

  81. Rabinowitz J. A method for preserving confidentiality when linking computerized registries [letter]. Am J Public Health 1998;88:836.

    CAS  Google Scholar 

  82. Pear R. Bush accepts rules to guard privacy of medical records. The New York Times, 2001 March 13, p. A1.

    Google Scholar 

  83. Information Policy Committee IITF. Privacy and the National Information Infrastructure: principles for providing and using personal information. Available at: http://nsi.org/Library/Comm/niiprivp.htm. Accessed 2005.

  84. Office for Civil Rights-HIPAA. Medical privacy-National Standards to Protect the Privacy of Personal Health Information. Available at: http://www.hhs.gov/ocr/hipaa. Accessed 2003.

  85. The HIPAA Privacy Rule. Information for researchers. Available at: http://privacyruleandresearch.nih.gov. Accessed 2003.

  86. Internal Market DG at the European Commission. Europa: The European Commission; Internal Market. Available at: http://europa.eu.int/comm/dg15/en/media/dataprot/index.htm. Accessed 2000.

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Shatin, D., Bright, R.A., Astor, B. (2006). Databases for Studying the Epidemiology of Implanted Medical Devices. In: Johnson, F.E., Virgo, K.S., Lairmore, T.C., Audisio, R.A. (eds) The Bionic Human. Humana Press. https://doi.org/10.1007/978-1-59259-975-2_7

Download citation

Publish with us

Policies and ethics